West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 396,000 | 326,700 | 265,500 | 337,400 | 297,300 |
| Receivables | 316,100 | 330,800 | 318,200 | 288,200 | 302,900 |
| Inventories | 230,400 | 232,300 | 226,100 | 214,500 | 206,800 |
| Other current assets | 61,600 | 54,500 | 57,800 | 54,300 | 43,100 |
| TOTAL | $1,004,100 | $944,300 | $867,600 | $894,400 | $850,100 |
| Non-Current Assets | |||||
| PPE Net | 812,100 | 822,900 | 814,700 | 822,000 | 822,000 |
| Investments And Advances | 97,400 | 95,400 | 94,900 | 91,200 | 90,500 |
| Intangibles | 135,300 | 137,900 | 124,700 | 126,100 | 127,300 |
| Other Non-Current Assets | 125,100 | 122,700 | 134,300 | 45,200 | 56,200 |
| TOTAL | $1,169,900 | $1,178,900 | $1,168,600 | $1,084,500 | $1,096,000 |
| Total Assets | $2,174,000 | $2,123,200 | $2,036,200 | $1,978,900 | $1,946,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 145,300 | 152,100 | 137,700 | 130,400 | 125,200 |
| Accrued Expenses | 72,600 | 59,000 | 53,500 | 64,500 | 67,300 |
| Other current liabilities | 88,200 | 86,500 | 82,400 | 78,900 | 78,600 |
| TOTAL | $335,000 | $313,200 | $301,100 | $283,700 | $288,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 195,100 | 196,000 | 195,500 | 196,000 | 196,200 |
| aiOther Non-Current Liabilities | 146,000 | 155,400 | 155,800 | 89,800 | 97,600 |
| TOTAL | $351,400 | $364,900 | $365,600 | $298,900 | $305,500 |
| Total Liabilities | $686,400 | $678,100 | $666,700 | $582,600 | $594,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,991 | 73,749 | 73,484 | 74,186 | 74,080 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 1,497,300 | 1,452,900 | 1,398,200 | 1,353,400 | 1,312,700 |
| Other shareholders' equity | -170,000 | -152,000 | -153,000 | -153,900 | -153,500 |
| TOTAL | $1,487,600 | $1,445,100 | $1,369,500 | $1,396,300 | $1,351,800 |
| Total Liabilities And Equity | $2,174,000 | $2,123,200 | $2,036,200 | $1,978,900 | $1,946,100 |